The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PI3K/AKT/mTOR genomic alterations in 94 patients with metastatic breast cancer in the phase I clinic at MD Anderson: Prevalence and association with response.
Jennifer J. Wheler
No relevant relationships to disclose
Filip Janku
No relevant relationships to disclose
Johnique T. Atkins
No relevant relationships to disclose
Stacy L. Moulder
No relevant relationships to disclose
Ralph Zinner
No relevant relationships to disclose
J. Jack Lee
No relevant relationships to disclose
Gerald Steven Falchook
No relevant relationships to disclose
Apostolia Maria Tsimberidou
No relevant relationships to disclose
Sarina Anne Piha-Paul
No relevant relationships to disclose
Daniel D. Karp
No relevant relationships to disclose
Aung Naing
No relevant relationships to disclose
Siqing Fu
No relevant relationships to disclose
David S. Hong
No relevant relationships to disclose
Vivek Subbiah
No relevant relationships to disclose
Philip J. Stephens
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Roman Yelensky
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Vincent A. Miller
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Vicente Valero
No relevant relationships to disclose
Razelle Kurzrock
No relevant relationships to disclose
Funda Meric-Bernstam
No relevant relationships to disclose